Ran Nussbaum Uro Gen Pharma Ltd. (URGN) insider trading activity

URGN Quotes by TradingView

Ran Nussbaum Transaction History

Date Transaction Value Shares Traded Form
Oct 21 2022
BUY
Exercise of conversion of derivative security
$285,114 $5.94 p/Share
47,999
Jun 16 2022
BUY
Exercise of conversion of derivative security
$11,055 $5.0 p/Share
2,211
Jun 06 2022
BUY
Exercise of conversion of derivative security
$5,150 $5.0 p/Share
1,030
Mar 25 2021
BUY
Exercise of conversion of derivative security
$11,055 $5.0 p/Share
2,211
Mar 24 2021
BUY
Exercise of conversion of derivative security
$5,150 $5.0 p/Share
1,030

Also insider at

KROS
Keros Therapeutics, Inc. Healthcare
PRVL
Prevail Therapeutics Inc.
Director
ELOX
Eloxx Pharmaceuticals, Inc. Healthcare
Director
RN

Ran Nussbaum

Director
Princeton, NJ

Track Institutional and Insider Activities on URGN

Follow UroGen Pharma Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells URGN shares.

Notify only if

Insider Trading

Get notified when an Uro Gen Pharma Ltd. insider buys or sells URGN shares.

Notify only if

News

Receive news related to UroGen Pharma Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on URGN